62-Year-Old Man Becomes First Patient In China Implanted With Rechargeable Neurostimulator For Chronic Pain
St. Jude Medical, Inc. (NYSE:STJ) announced that a 62-year-old man from Shenzhen, Guangdong province has become the first patient in China to be implanted with the Eon™ neurostimulator, a rechargeable device used to help manage chronic pain. Despite prior back surgeries, the patient suffered from chronic back pain for more than a decade. The Eon neurostimulator, which is the first rechargeable spinal cord stimulator to be approved for use in China, was recently approved by the Chinese State Food and Drug Administration (SFDA) for the management of chronic low back pain and pain from back surgeries that have failed. "Chronic pain is a serious health issue in China, " said Professor Zhang De Ren, M.
Carole Riggs, a retired teacher and school principal, points to her work during one Christmas vacation bending, twisting and sitting on the floor to create games and teaching aids as the primary culprit behind many years of back pain. Burak M. Ozgur, M.D., the neurosurgeon at Cedars-Sinai Medical Center who performed the minimally invasive procedures that relieved the pain, attributes the problem to adult degenerative scoliosis affecting the disks and structures between five vertebrae (thoracic 12 to lumbar 5) in Riggs' lower back. The operations took place in Oct. 2008, and Riggs, 71, has celebrated a year without back pain for the first time in about three decades.
A late examination article published in the Journal of the American Academy of Orthopedic Surgeons should help convince many patients with low back pain to favor physical therapy as a elementary edge of treatment for their condition, according to the American Physical Therapy Convention (APTA). The review, published in February 2009, recommends that in most cases of symptomatic lumbar degenerative cd disease, a general cause of low back pain (LBP), the most convincing treatment is physical therapy combined with anti-inflammatory medications. Approximately 75 to 85 percent of adults testament be affected by low back pain during their lifetimes.1 Symptomatic lumbar degenerative disc disease develops when a disc weakens (often due to repetitive strain), is injured, or deteriorates from aging.
Lumbar cd degeneration is an agonizing condition that affects millions of people, on the other hand two University of Alberta researchers hog identified some of the genes that are causing problems. Michele Crites-Battie and Tapio Videman, in the Academy of Rehabilitation Medicine, have discovered eight genes that are directly related to disc degeneration. "We create more genes associated with disc degeneration than was discovered in 30 prior studies, " said Videman. "This is as well exciting." The team started by studying 25 particular genes they thought could be linked to the disease. They picked these "candidate" genes based on the views of two relevant experts in the field who Crites-Battie and Videman accept collaborated with through the years.
Layoffs, loss of insurance, and rising medical costs are forcing people to gamble with their health. According to a recent survey, 25 percent of respondents said they have skipped a doctor's sojourn because of cost, while 20 percent of U.S. residents say they have bother paying medical bills(1). Delaying visits to the doctor's employment or forgoing preventive care can de facto increase the cost of medical distress while prolonging pain and recovery time. Back grief is one of the most common reasons for chronic disability and incapacity for business in the western world, and the moment important target why Americans see physicians; upper respiratory infections are first.
A study aimed at overcoming problems with treatments for a colloquial cause of back pain has picked up one of the most prestigious prizes in spinal research. The proof paper produced by the troupe of surgeons, engineers and physicists at The University of Nottingham has scooped two out of three categories of the annual ISSLS Liking for Lumbar Backbone Research. Awarded by the International Society for the Study of the Lumbar Spine (ISSLS), the accolade is designed to encourage innovative new labour in the globe and comes with a $15, 000 cash cherish for everyone successful researcher or team. The multi-disciplinary attributes of the Nottingham paper, entitled What control does sustained mechanical load have on diffusion of small solutes in the human intervertebral discs, was recognised when judges decided to honour it in both the bioengineering studies and studies in other basic science areas categories.
Shock Meds Are Most Daily Goal Of Death After Spinal Fusion Surgery: Middle-Aged Men With Disk Deterioration At Highest Risk
Pain medications are involved in more than 20 percent of deaths occurring in the agedness after spinal fusion surgery for low back pain, reports a scan in the April 1 question of Spine. The journal is published by Lippincott Williams & Wilkins, a effects of Wolters Kluwer Health, a salient provider of confidence and business intelligence for students, professionals, and institutions in medicine, nursing, allied health, pharmacy and the pharmaceutical industry. The risk of analgesic-related death is highest among patients with degenerative disc disease (DDD) principally men aged 45 to 54, according to the new research, led by Dr. Sham Maghout Juratli of Wayne State University School of Medicine, Detroit.
Back Agony Treatment Needs To Catch Up With Evidence: Handle And Other Proven Treatments Are Underused
People with back grief application a lot of medical treatments, on the contrary often not the ones with the strongest evidence of effectiveness, according to a glance at in the April 1 controversy of Spine. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health, a substantial provider of information and business intelligence for students, professionals, and institutions in medicine, nursing, allied health, pharmacy and the pharmaceutical industry. The results propose that some treatments with the strongest evidence of ease for patients with low back anguish such as therapeutic exercise and antidepressants are less usually used.
Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) announced the results of its recently completed North American Period III clinical analysis for its twice-daily formulation of tramadol and acetaminophen (study 06CCL3-001). Discover 06CCL3-001 was a multi-centre, randomized, double-blind, parallel-arm study that compared the efficacy and safety of Labopharm's twice-daily tramadol-acetaminophen formulation to placebo in the treatment of interchange to severe acute low back pain. A complete of 277 patients were included in the study. Thirteen percent (13%) of patients in the active treatment battery discontinued early (12% due to adverse events) and 5% of patients in the placebo batch discontinued early (2% due to adverse events).
With 4.2 million administrative professionals logging lenghty hours at their desks, it's not surprising insurance companies dish away $50 billion a year to Americans suffering from back pain. This Administrative Professionals Day, observed Apr 22, the Laser Spine Institute is helping administrative support professionals find relief. Simple changes in diurnal activities can ofttimes alleviate anxiety without the need for surgery. LSI Employer of Physical Therapy, Irene Rademeyer PT.OCS., identifies common mistakes in the workplace that guidance to increased back malaise and offers ways to get back to office pain free. With facilities in Tampa and Scottsdale, LSI offers a minimally invasive surgical approach with an divide measuring less than one inch for added serious issues and a five-day process from surgery to recovery, drastically reducing the time it takes for professionals to be pain-free and back in the office.